STOCK TITAN
  1. Home
  2. Sec-filings
  3. RMTI
  4. [Form 4] ROCKWELL MEDICAL, INC. Insider Trading Activity

Director John Cooper gets 9,633 RSUs at Rockwell Medical (RMTI)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

COOPER JOHN G reported acquisition or exercise transactions in this Form 4 filing.

Rockwell Medical director John G. Cooper received an equity award rather than buying shares on the market. On July 1, 2026, he was granted 9,633 restricted stock units of common stock at no cash cost as compensation.

The RSUs vest on July 1, 2027, subject to his continued service through the 2027 Annual Meeting. Effective at 12:01 a.m. on July 1, 2026, Rockwell Medical implemented a 1-for-10 reverse stock split, and Cooper’s equity awards and holdings were proportionally adjusted. Following these adjustments and the reported grant, he beneficially owns 23,670 shares of common stock directly.

Positive

  • None.

Negative

  • None.
Insider COOPER JOHN G
Role null
Type Security Shares Price Value
Grant/Award Common Stock 9,633 $0.00 --
Holdings After Transaction: Common Stock — 23,670 shares (Direct, null)
Footnotes (1)
  1. Restricted stock units vest on July 1, 2027, subject to the Reporting Person's continued service to the Issuer through the 2027 Annual Meeting. Effective at 12:01 AM on July 1, 2026, the Issuer effected a 1-for-10 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, the shares listed under Amount of Securities Beneficially Owned Following Reported Transaction(s) reported in this Form 4 have been adjusted to reflect the 1-for-10 reverse split.
RSU grant size 9,633 shares Restricted stock units granted on July 1, 2026
Grant price per share $0.00 per share Equity award, not open-market purchase
Shares owned after transaction 23,670 shares Beneficially owned following reported transaction(s)
Reverse split ratio 1-for-10 Reverse split effective July 1, 2026
Restricted stock units financial
"Restricted stock units vest on July 1, 2027, subject to the Reporting Person's continued service"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
1-for-10 reverse split financial
"the Issuer effected a 1-for-10 reverse split of the Issuer's common stock"
equity awards financial
"In addition, proportionate adjustments were made to the Issuer's outstanding equity awards."
Equity awards are payments to employees or directors made in the form of company stock or rights to buy stock later, serving as a way to share ownership rather than cash. For investors, they matter because they align staff incentives with company performance, can increase the number of shares outstanding over time (which can reduce each share’s claim on profits), and create compensation costs that affect reported earnings.
beneficially owned financial
"Amount of Securities Beneficially Owned Following Reported Transaction(s) reported in this Form 4"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
COOPER JOHN G
(Last)(First)(Middle)
C/O ROCKWELL MEDICAL, INC.
30142 WIXOM ROAD
(Street)
WIXOM MICHIGAN 48393
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
ROCKWELL MEDICAL, INC. [ RMTI ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/01/2026A(1)9,633A$023,670(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Restricted stock units vest on July 1, 2027, subject to the Reporting Person's continued service to the Issuer through the 2027 Annual Meeting.
2. Effective at 12:01 AM on July 1, 2026, the Issuer effected a 1-for-10 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, the shares listed under Amount of Securities Beneficially Owned Following Reported Transaction(s) reported in this Form 4 have been adjusted to reflect the 1-for-10 reverse split.
Remarks:
/s/ Megan Timmins, Attorney-in-Fact for John G. Cooper07/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Rockwell Medical (RMTI) director John G. Cooper receive in this Form 4?

He received 9,633 restricted stock units of Rockwell Medical common stock as an equity award, at no cash cost. This is compensation-related, not an open-market purchase or sale, and increases his direct beneficial ownership position.

When do John G. Cooper’s 9,633 RSUs from Rockwell Medical (RMTI) vest?

The 9,633 restricted stock units vest on July 1, 2027, provided he continues serving the company through the 2027 Annual Meeting. If that service condition is not met, the unvested units may not be earned under the award’s terms.

How many Rockwell Medical (RMTI) shares does John G. Cooper own after this transaction?

After the reported RSU grant and related adjustments, he beneficially owns 23,670 shares of Rockwell Medical common stock directly. This figure reflects the company’s 1-for-10 reverse stock split adjustments applied to his existing equity holdings and awards.

Did John G. Cooper buy or sell Rockwell Medical (RMTI) shares on the market?

No market buy or sell is reported. The Form 4 shows an acquisition coded as a grant or award of 9,633 restricted stock units, with a reported price per share of $0.00, indicating compensation rather than an open-market transaction.

What reverse stock split did Rockwell Medical (RMTI) implement on July 1, 2026?

Effective at 12:01 a.m. on July 1, 2026, Rockwell Medical completed a 1-for-10 reverse split of its common stock. This reduced the number of shares outstanding and led to proportional adjustments in outstanding equity awards, including Cooper’s reported holdings.

How did Rockwell Medical’s (RMTI) reverse split affect John G. Cooper’s Form 4 holdings?

The 1-for-10 reverse split reduced the number of shares he held, and the company proportionally adjusted his outstanding equity awards. The 23,670 shares reported as beneficially owned after the transaction reflect this reverse-split adjustment.